Post-Ebola Syndrome in Sierra Leone

Article

Researchers from the University of Liverpool's Institute of Translational Medicine have conducted a study of Ebola survivors to describe the medical problems they continue to have after recovering from the acute disease. The results have been published in the journal Emerging Infectious Diseases.

Ebola survivor and medical team at her discharge ceremony from the Ebola Treat Unit 34th Regiment Military Hospital Freetown, Sierra Leone on Feb. 5, 2016. Courtesy of MG Semple

Researchers from the University of Liverpool's Institute of Translational Medicine have conducted a study of Ebola survivors to describe the medical problems they continue to have after recovering from the acute disease. The results have been published in the journal Emerging Infectious Diseases.

This week it was widely reported that a British Nurse, Pauline Cafferkey, who was thought to have made a full recovery from Ebola, has been taken to a hospital for a third time due to what health officials described as delayed complications from the virus -- raising further questions about the long-term impact of the disease on survivors. Cafferkey is one of thousands of survivors who have reported suffering from issues that appear to be related to late effects of the virus.
 
To find out more about the symptoms that persist or develop after hospital discharge Dr. Janet Scott and Dr. Calum Semple from the University's Institute of Translational Medicine, and their colleagues at the 34th Regiment Military Hospital in Freetown, Sierra Leone, examined and interviewed every survivor discharged from the Ebola Treatment Unit at that hospital.

From Dec. 1, 2014 through March 30, 2015, they treated 84 persons with Ebola, of whom 44 (52%) survived. Survivors were interviewed and examined at their first follow-up appointment three weeks after discharge, which followed two negative blood tests for Ebola.

Of the 44 people studied:

•70% reported musculoskeletal pain
•48% reported having headaches
•14% reported having problems with their eyesight 

Scott, says, "The phenomenon of 'Post-Ebola Syndrome' is still not very well understood. This is due in part to the fact that, in the past, the disease's high fatality rate has meant there haven't been many survivors. Due to the scale of the last outbreak we now have access to more survivors who can help us understand more about the damage that this virus causes and the long term problems it causes. There has been mounting evidence of both mental and physical health problems in Ebola survivors after the virus is cleared from the bloodstream. In some cases these health problems, such as damage to joints, brain and eyes, may be caused by Ebola virus persisting and causing damage in some of the compartments of the body that are less accessible to the immune system. Currently, there is a lot of anecdotal evidence of Post-Ebola Syndrome. The continued study of survivors is necessary if we are to learn more about how the Ebola virus works and how it affects them. The Ebola epidemic is waning, but the effects of the disease will remain."

Semple notes, "Ebola has revealed to the world the fragility of the health systems in West Africa. The impact of Ebola has been profound with 28639 cases and 11316 deaths. As interest in Ebola wanes, we must not overlook that most of the 17 thousand survivors in West Africa are experienced on-going health problems and that 12 thousand children have been orphaned. There has also been shocking secondary impact on other health and education services."

The paper, "Post-Ebola Syndrome, Sierra Leone," can be found HERE.

Source: University of Liverpool

Related Videos
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Related Content